News Hub | News Direct

Nuestro Stories and LatiNation Media Announce First-Look Co-Production Partnership Spanning Original IP, Digital Properties, Films, and Podcasts

Nuestro Stories

Nuestro Stories and LatiNation Media, two trailblazing Latino-owned media companies, have joined forces in an unprecedented first-look co-production and content distribution partnership. The alliance spans digital platforms, films, series, and audio content, representing a significant leap forward in elevating Hispanic voices and stories within the media landscape. The collaboration was unveiled during the prestigious 2024 IAB NewFronts, marking a pivotal moment in Hispanic media evolution. “This collaboration is the result of our profound mutual admiration for each other’s creative endeavors and and our shared belief that together, we can go farther, faster, and stronger,” said Angela Sustaita-Ruiz, Chairwoman of Brilla Media Ventures, the holding company of Nuestro Stories. “The fact that two iconic storytelling brands are uniting for some of their biggest ideas bodes well for creators and filmmakers, as well as for brands who encourage but rarely see Latino-owned companies like us collaborating like this.” The inaugural project for the partnership is the highly anticipated Entre2Mundos, an anime series rooted in Mesoamerican culture that is tailored to US Hispanic audiences. The profound affinity for Anime within Hispanic culture has been on the rise for decades. Today, as Gen Z consumers openly express their love and fandom for Anime, the genre is experiencing a surge in attention, captivating the interest of younger Hispanic generations. “LatiNation Media’s core ideology involves sharing impactful content with our audience that reflects their diverse and expansive lives. We are thrilled to partner with Nuestro Stories and bring Entre2Mundos to life – the first Anime series of its kind for Latino audiences on both national broadcast and streaming. This is an exciting initial step toward more fan-first programming for us,” said Bruno Ulloa, President of LatiNation Media. As Nuestro Stories and LatiNation Media embark on this shared journey of innovation and inclusivity, they reaffirm their commitment to championing diverse narratives and fostering authentic representation in media and entertainment. About Nuestro Stories Nuestro Stories is the flagship media brand of Brilla Media Ventures, and was founded with the premise of celebrating Latino heritage, history and origins every day. We provide engaging cultural content for multicultural marketers through our owned and operated platforms, Nuestro Stories and Brilla Latina. Our offerings also include programmatic advertising technology services for scalable media delivery, influencer marketing, creative studio services, and activations. Nuestro Stories is led by Angela Sustaita-Ruiz and Manny Ruiz, creators of Hispanicize, and trailblazers in the Hispanic media, social and influencer marketing industries, the Latino press release wire industry, and the first network of Hispanic print media companies online. About LatiNation Media LatiNation Media is a bilingual, multi-platform media company whose mission is to transform Latino representation in the modern media landscape by creating content that organically represents today’s Latino experience. We distribute across every platform including linear TV, streaming, the web, mobile, and social. Latination Media’s brands include Latino Alternative Television (LATV) linear and LATV FAST Network, LatiNation Digital, LatiNation Studios, and LatiNation Creative. Grounded in over two decades of creating award-winning bilingual content, its flagship linear channel LATV is seen in 81% of U.S. Hispanic Households and the top 47 U.S. DMAs. The company’s Digital Ad Network reaches over 68% of the U.S. population and has +189mm monthly uniques. LatiNation content emphasizes young Latino culture and Latina empowerment, as well as LGBTQ+ and Afro-Latino pride. For more information, visit www.latination.com. Contact Details Nuestro Stories Alex Hernandez +1 305-720-6313 alex@brillamedia.com Bolte Media hanna@boltemedia.com Bolte Media dina@dinawhitepr.com

May 09, 2024 11:35 AM Eastern Daylight Time

Image

Locality Appoints Sandy Ashendorf as Executive Vice President, Law and Business Affairs

Locality

Locality, the industry’s preeminent local video advertising solutions provider, today announced the appointment of Sandy Ashendorf as Executive Vice President, Law and Business Affairs. In this role, Ashendorf will be responsible for identifying and advising on legal issues affecting all aspects of Locality’s operations, including ongoing and new businesses. She will also assist with developing and implementing strategies affecting the company's growth and support corporate initiatives and projects. Ashendorf will report to Keith Kazerman and Ann Hailer. Ashendorf brings over 35 years of experience in the media industry to Locality. During that time, she held leadership roles at several major media companies, including Viacom, EPIX and BBC Worldwide America, where she ran sales teams and was responsible for legal issues affecting content distribution. She has served as a consultant for numerous companies across a variety of media and at various stages of development. Sandy served on the Board of Directors of the T. Howard Foundation and was Chair of WP Theater. "We’re excited to welcome Sandy to the Locality team," said Ann Hailer, president of broadcast at Locality. "Her extensive experience in the media industry and her deep understanding of the legal and business challenges facing companies today will be invaluable to Locality as we continue to grow and expand our business." “This is an important strategic move forward for our company, as we continue to grow and evolve our solutions in the local market. We are thrilled to welcome Sandy aboard,” said Keith Kazerman, president of streaming at Locality. "After consulting at Locality for over a year, it’s wonderful to become a part of the company’s leadership,” said Ashendorf. “I am delighted to be part of an incredible team poised to transform the local ad sales industry across both traditional TV and streaming platforms, and to drive strategic growth for the company and our clients.” Locality is the industry’s preeminent local television solutions provider, committed to addressing the evolving needs of advertisers by unlocking the power of local and driving dollars to the local video marketplace. Formed through the union of CoxReps and Gamut, Locality brings together the best talent in both broadcast and streaming. With more than 11 locations in the US, Locality helps brands tap into the mindset of the local consumer and precisely reach optimal markets, nationally. Having served more than 1,500 ad agencies and 4,500 advertisers, to date, Locality offers the best premium inventory that the industry has to offer to help brands optimize their spend and target audiences at scale. For more information, please visit www.locality.com. Contact Details Mackenzie Sikora mackenzie@kitehillpr.com

May 09, 2024 11:14 AM Eastern Daylight Time

Nextech3D.ai Unveils Success of AI-Powered 3D Model Search Engine, Accelerating Production by 40%

Nextech3D.AI

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to revealed the triumph of their proprietary AI-Powered 3D model search engine launched in Q1, 2024. This cutting-edge AI technology, powered by Nvidia's GPUs, revolutionizes the 3D modeling process by significantly enhancing speed and scalability. Using images as input, the AI search engine swiftly sifts through Nextech's extensive library of 3D models and meshes, recommending the closest match to the provided image. According to Gappelberg, the implementation of this AI search engine has led to a remarkable 40% increase in production, enabling the company to boost its output of 3D models significantly. Nextech3D.ai remains committed to advancing its proprietary technology and has plans to patent its breakthrough AI innovations tailored for the mass scale of 3D models, identifying this market segment as a key growth opportunity in 2024. Developed in-house by the company's team of AI engineers and scientists, the AI-powered search engine effortlessly scours Nextech's vast repository of over 200,000 3D models, matching colors, textures, and shapes to deliver precise results. This achievement underscores Nextech3D.ai's technical prowess and expertise in harnessing AI to drive innovation in the 3D modeling industry. Contact Details Proactive United States +1 347-449-0879 action@proactiveinvestors.com

May 09, 2024 10:41 AM Eastern Daylight Time

Video

SFAA Members Elect New Board, Honor Outgoing Chair at Annual Meeting

SFAA

The Surety & Fidelity Association of America (SFAA), a nonprofit, nonpartisan trade association representing all segments of the surety and fidelity industry, held its annual meeting this past week with more than 185 members and guests attending. Robert Murray, SFAA Chair, Executive Committee Member, Head of Surety, Zurich North America, and Ryan Work, SFAA president and CEO, presided over the event, providing updates on SFAA’s accomplishments and ongoing initiatives. SFAA members were on hand to celebrate outgoing SFAA Chair Robert Murray after his two-year term, in addition to congratulating him on his upcoming retirement. Murray will be succeeded as chair by Michael Keimig, president and CEO of Markel Surety Corporation. Keimig has been an active participant in the SFAA for over a decade, most recently as a Board and Executive Committee member. Videos celebrating SFAA’s accomplishments throughout 2023 and honoring the 2023 Surety Industry Awards winners were also shared. The SFAA Membership elected the following Board of Directors and Executive Committee in a unanimous vote. Officers and Executive Committee Members Michael Keimig Stephen Ruschak John F. Welch Rick Ciullo Timothy Mikolajewski Antonio C. Albanese Bryce Grissom Other Elected Board Members Ken Bearley John Guglielmo Stephen M. Haney James Kawiecki Matt Lubin, Robert Murray Alan Pavlic Sharon Sims Gary Stumper Larry Taylor Mike Zurcher The Surety & Fidelity Association of America (SFAA) is a nonprofit, nonpartisan trade association representing all segments of the surety and fidelity industry. Based in Washington, D.C., SFAA works to promote the value of surety and fidelity bonding by proactively advocating on behalf of its members and stakeholders. The association’s more than 425 member companies write 98 percent of surety and fidelity bonds in the U.S. For more information visit www.surety.org. Contact Details Peter Roth +1 703-401-0676 proth@surety.org Company Website https://surety.org/

May 09, 2024 09:55 AM Eastern Daylight Time

Boeing’s Chairman is Leaving Under a Cloud – So Why Does Exxon Want Him on Their Board?

NLPC

In a case of corporate elitists’ blindness at best, and ineptitude in governance at worst, Exxon Mobil Corporation’s directors have renominated Lawrence “Larry” Kellner, who is also the departing Chairman of the crisis-plagued Boeing Company, to their own board. Kellner, a former Continental Airlines Chairman/CEO, left the now-defunct (merged with United) company in late 2009 and joined Boeing’s board of directors in 2011. He was elevated to chairman in late 2019, and his tenure has been marked with failures both financial and reputational. As anyone who follows air travel news knows, Boeing has likely endured the worst year of any U.S.-based corporation due to numerous troubling safety incidents, with the penultimate occurrence in January, when a door plug blew off an Alaska Airlines flight at 16,000 feet, imperiling passengers and crew. In addition to that high-profile episode, Kellner has presided over a cascade of devastating headlines related to Boeing’s quality and safety record. It’s gotten so bad that now every airliner performance glitch, regardless of the responsible party, is now headlined as a “Boeing plane” incident. Yet, inexplicably, ExxonMobil wants Kellner to serve another year on its board, which he joined in 2023. As a result, National Legal and Policy Center, a shareholder in both Boeing and Exxon, is calling for fellow investors to vote against Kellner for the energy company’s annual meeting on May 29. “It’s incredible to have to even ask, but after the last five years-plus that Boeing has had, Larry Kellner is properly leaving its board – so why do Exxon directors think he deserves a seat with them?” said Paul Chesser, director of NLPC’s Corporate Integrity Project. “Is this about strong governance to protect shareholder assets, or just keeping the social club together until something catastrophic happens – like what just happened at Boeing?” Earlier this week NLPC filed a proxy memo with the Securities and Exchange Commission which further explained why it believes Kellner has no business serving on a corporate board at this time, much less the largest U.S.-based energy company in the world. Kellner, along with exiting CEO Dave Calhoun, were supposed to be the leadership pair to improve Boeing’s performance after the firing of previous CEO Dennis Muilenburg. Instead the company’s performance only worsened, with its stock price being almost halved since Kellner took over as Chairman. NLPC also released a short video on Thursday that highlights Boeing’s mishaps under Kellner’s leadership, and questions why ExxonMobil would want to keep him on its governance team. The oil giant’s board, in exhibiting the ultimate in tone-deafness, even plans to keep Kellner on the company’s safety committee! “There’s a reason Larry Kellner is leaving Boeing’s board, and that reason is failure,” Chesser added. “Exxon is not in business so it can provide soft landings for mediocre executives. Nonetheless his colleagues put him on the proxy ballot for the board, so our fellow shareholders should do the right thing and vote against him.” ### For more information or to schedule an interview with Paul Chesser, contact Dan Rene at 202-329-8357 or drene@nlpc.org. Please visit http://www.nlpc.org. Founded in 1991, the National Legal and Policy Center promotes ethics in public life through research, investigation, education and legal action. Contact Details National Legal and Policy Center Dan Rene +1 202-329-8357 drene@nlpc.org Company Website http://www.nlpc.org

May 09, 2024 09:49 AM Eastern Daylight Time

Power One Resources Corp CEO Discusses Promising Projects and Developments in Exclusive Interview

Power One Resources Corp

Power One Resources Corp CEO Karim Rayani joined Steve Darling from Proactive to delve into the company's recent progress and future plans. Since going public in January as a spin-out from Marvel Discovery, Power One has been gearing up to drill the Pecors Project, a significant nickel system in Canada. Spanning an impressive seven kilometers in length, three kilometers in width, and extending two to three kilometers in depth, this project boasts a historic resource of 20 million tons and was originally explored for uranium in the 1950s. In addition to the Pecors Project, Power One is advancing another venture in British Columbia, situated near Prince George, within one of Canada's renowned rare earth belts. While this project is currently secondary in focus, it is expected to undergo development activities in the coming year. Notably, the company has recently added Dr. Wazir Khan, an experienced geologist with a wealth of international expertise, to its team. Dr. Khan's knowledge is poised to play a pivotal role in advancing Power One's projects. Despite challenges like delayed drilling due to snow melt, Power One remains optimistic about the potential of its projects, particularly the nickel system. If their geological thesis holds true, the Pecors Project could emerge as a world-class deposit, underlining the company's commitment to exploration and growth in the resource sector. Contact Details Proactive North America +1 604-688-8158 na-editorial@proactiveinvestors.com

May 09, 2024 09:45 AM Eastern Daylight Time

Video

News Release

Cadiz, Inc. (NASDAQ CDZI) Innovating Water Solutions: Addressing A New Reality

CDZI

Climate change is causing massive disruption in the water industry around the world – and billions of dollars are being thrown at infrastructure projects to capture, store, treat, and manage water supplies, particularly in the Southwest, where tens of millions of people are dependent upon the fragile Colorado River that feeds Lake Mead, the largest reservoir in the US. With climate change wreaking havoc on water supplies around the world and the company’s recent acquisition of pipelines and treatment technology in conjunction with their water supply and storage assets, Cadiz today has some of the most valuable water assets in the US and is in a position to monetize them. Cadiz’s core asset is the aquifer system that sits under their land. With 30-50 million acre-feet of water already in storage-twice as much water as there is in Lake Mead–- and a pipeline network that stretches across hundreds of miles in Southern California -- Cadiz is positioned to operate one of the largest water banks in the world in a region of the world that desperately needs water security. In this dynamic landscape, Cadiz, Inc. (NASDAQ: CDZI) emerges as a pioneering force in water solutions. Established in 1983, Cadiz is a California-based company dedicated to providing access to clean, reliable, and affordable water through a comprehensive range of solutions encompassing water supply, storage, pipelines, and treatment technologies. Cadiz is a totally different company compared to the Cadiz of 20 years ago. Through strategic acquisitions and the deployment of cutting-edge innovations, Cadiz is positioning itself as a leader in addressing the multifaceted challenges posed by climate change to water access and could be a smart stock to keep an eye on. Perfectly Positioned in the World of Water Solutions Cadiz, Inc. (NASDAQ: CDZI) is a California-based company dedicated to providing access to clean, reliable, and affordable water. With a robust portfolio comprising 45,000 acres of land in California, 2.5 million acre-feet of water supply, and 220 miles of pipeline assets, CDZI is well-positioned to address the evolving needs of the water treatment systems market. Through a series of initiatives and partnerships, Cadiz continues to demonstrate its commitment to driving innovation and sustainability in the water sector. Cadiz's Vision CDZI’s recent announcements underscore the company's vision and commitment to sustainable growth. In a significant move, the company announced Susan Kennedy's transition from Executive Chair of the Board to CEO, effective January 1, 2024. This leadership transition signals Cadiz's focus on scaling up development and operational capabilities to meet the evolving needs of the water treatment market. Kennedy's appointment, along with Scott Slater's continued advisory role, reflects Cadiz's dedication to strong leadership and operational excellence. Further exemplifying the CDZI approach is its collaboration with Fenner Gap Mutual Water Company and the Victor Valley Wastewater Reclamation Authority. This partnership aims to develop integrated water infrastructure in San Bernardino County's Mojave Basin region, leveraging recycled water from wastewater treatment plants and pipeline facilities to enhance water supply efficiency and groundwater quality. By fostering innovative partnerships, Cadiz is driving sustainable water management practices and contributing to the resilience of local communities. Securing Investments CDZI’s recent financing agreements highlight the company's financial stability and commitment to long-term growth. On March 15, 2024, CDZI secured a financing agreement totaling $41.2 million with Heerema International Group Services BV, extending its debt maturity to 2027. This agreement provides Cadiz with additional liquidity to accelerate the development of water supply, pipeline, filtration, and storage assets, positioning the company for sustained growth and value creation in the water solutions market. Additionally, Cadiz Inc.’s successful completion of a financing transaction on April 25, 2024, led by Heerema International Group Services SA, further strengthens the company's financial position and provides liquidity to support the development of water supply projects in Southern California. With a solid financial foundation and support from key investors, Cadiz is well-equipped to execute its growth strategy and deliver innovative water solutions to address the region's growing water challenges. Partnering for Impact CDZI’s recent partnership with Solstra Communities California underscores its commitment to driving sustainable development and addressing California's urgent housing needs. Through this agreement, CDZI will deliver water from the Cadiz Water Supply and Storage Project to support the development of sustainable housing units, contributing to the creation of vibrant, resilient communities. By partnering with Solstra, Cadiz is demonstrating its commitment to leveraging water resources to drive positive social and environmental impacts. Enhancing Market Visibility In a move to enhance market visibility and investor outreach efforts, CDZI announced its engagement with MZ Group on May 7, 2024. By partnering with MZ Group, Cadiz aims to strengthen its investor relations and raise awareness of its innovative water solutions and sustainable business practices. This partnership reflects Cadiz's commitment to expanding its market presence and communicating its growth story to a broader audience. Cadiz, Inc. (NASDAQ: CDZI) stands at the forefront of the water treatment systems market, driving innovation, sustainability, and growth through initiatives and partnerships. With a steadfast commitment to delivering clean, reliable water and addressing the evolving needs of communities and industries, CDZI continues to shape the future of water solutions in a rapidly changing world. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained by Awareness Consulting to assist in the production and distribution of content related to CDZI. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details Mark McKelvie +1 585-301-7700 Company Website http://razorpitch.com

May 09, 2024 09:30 AM Eastern Daylight Time

Texas’ Leading Hormone Provider Expands Cutting-Edge Preventative Screening Tool to All Clinics

Forum Health

Hormones by Design, a Forum Health provider and leader in hormone replacement therapy, has acquired DITI Imaging – a pioneer in digital infrared thermal imaging. This strategic move combines the expertise of both companies to offer comprehensive and preventative health care to two of its five renown Texas locations. Learn more about Hormones by Design. Digital infrared thermal imaging (DITI) is a non-invasive, radiation-free screening tool to detect early signs of inflammation and abnormal blood flow patterns, which may be precursors to various health conditions. By identifying these indicators early, patients can proactively address potential issues before they develop into more serious conditions. Phil Hagerman, Forum Health CEO: “ With 1 in 8 women diagnosed with breast cancer and chronic inflammatory diseases on the rise, early detection is paramount. This acquisition underscores our commitment to advancing personalized, integrative healthcare and providing the latest, top-of-the-line technology to help our patients achieve optimal health.” DITI is the only screening tool capable of detecting inflammation and associated heat patterns unlike X-rays, mammograms, MRIs and ultrasound tests. Some of the many health conditions DITI can screen for are: Breast cancer Early indications of asymptomatic and systemic inflammatory and degenerative processes Systemic, artery, dental, and sinus inflammation Unexplained and referred pain, including arthritis and nerve damage Fibromyalgia and digestive disorders Overactive and underactive thyroid conditions Dr. Melissa Miskell, Hormones by Design founder: "We’re thrilled to welcome DITI Imaging into the Hormones by Design family. It allows us to expand our preventative healthcare offerings, better monitor the effects of hormone therapy, more comprehensively treat patients with thyroid conditions, and help people maintain optimal health as they age.” Patients will have access to advanced screening services, including breast, full-body, and region-specific imaging, in addition to personalized BHRT options. Schedule an appointment or find a Hormones by Design location near you. About Forum Health, LLC Forum Health, LLC is a nationwide provider of personalized healthcare steeped in the powerful principles of functional and integrative medicine. Our providers take a root-cause approach to care exploring lifestyle, environment, and genetics to help each patient achieve their ultimate health goals. Members have access to advanced medical treatments and technology, with care plans informed by data analytics and collaborative relationships. For more, visit www.forumhealth.com. Contact Details Forum Health Britt Wittelsberger +1 410-852-0738 bwittelsberger@forumhealth.com Company Website https://forumhealth.com

May 09, 2024 08:50 AM Eastern Daylight Time

6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings

IGC Pharma, Inc. (IGC)

By Faith Ashmore, Benzinga Over 6.7 million Americans aged 65 and older are living with Alzheimer’s disease (AD) and this number is predicted to grow to 13.8 million by 2060. AD is the sixth leading cause of death in the U.S. and in 2023, it was projected to cost the U.S. $345 billion. Alzheimer's disease is characterized by a gradual decline in memory, thinking, behavior and social skills; however, a lesser-known subsection of Alzheimer’s patients – despite a prevalence of 40%-80% in the patient population – suffer from Agitation in Alzheimer’s Disease (AAD). AAD is associated with higher admission rates to assisted living facilities, higher use of medications, higher rates of long-term hospitalizations and higher mortality rates for Alzheimer’s patients. This brings a significant emotional and financial cost to patients and caregivers. Currently, there is no perfect treatment for AD or ADD. Otsuka’s (OTC: OSUKF) Rexulti is one of the major medications currently being explored as a potential treatment for Alzheimer's disease. It was originally developed as an atypical antipsychotic to help treat mental health illnesses, and it is believed to work by affecting the activity of certain neurotransmitters in the brain. Due to this, ongoing research is investigating its potential to address the behavioral and psychological symptoms often associated with the condition, such as agitation and aggression, but some concerns are yet to be addressed. One of the major criticisms of Rexulti is that it carries a black box warning regarding the increased risk of death in elderly patients with dementia-related psychosis. Patients have reported adverse events associated with the drug like restlessness, weight gain and sleepiness. IGC Pharma (AMEX: IGC) is looking to an alternative to existing drugs with its drug, IGC-AD1, which has been specifically designed to target the underlying causes of AAD and aims to fill the gap for a safe and effective therapy. IGC Pharma began developing IGC-AD1 in 2017, and it was approved by the FDA as an investigational new drug in 2019. IGC-AD1 is designed to target neuroinflammation and dysfunction of the CB1 receptor. This investigational drug contains THC as one of two active pharmaceutical agents. THC is the primary psychoactive compound found in the cannabis plant. IGC-AD1 is undergoing extensive clinical trials to evaluate its effectiveness and safety in treating Alzheimer's disease. After a successful phase 1 clinical trial that resulted in patent protection in the U.S., the company has moved on to phase 2 trials. The phase 2 clinical trial, begun in 2023, encompasses 20 sites across the United States and Canada. With a target of 146 participants, this trial focuses on determining the efficacy of IGC-AD1 in alleviating agitation in Alzheimer's patients. The company has just announced the results of an interim analysis of its ongoing phase 2 trial. The main objective of the study is to evaluate the change in AAD over six weeks, utilizing the Cohen Mansfield Agitation Inventory (CMAI). According to IGC Pharma, the study showed that patients who were given IGC-AD1 had a more significant reduction in agitation levels compared to those who were given a placebo, with positive effects being observed as early as week two of the trial. At the six-week mark, the difference in agitation levels between the IGC-AD1 group and the placebo group was quite noticeable, with an effect size of 0.66 according to Cohen's d measure. The mean difference in the CMAI scores between the active treatment and placebo was -10.45, which indicates a meaningful contrast. Additionally, at the two-week mark, a secondary evaluation showed a positive effect size of 0.79 for IGC-AD1 compared to the placebo. If IGC-AD1 continues to perform well in clinical trials, it could be an effective, simpler and faster treatment option for patients – and importantly, the company is aiming to deliver a product with full approval from the FDA without major black box warnings. The formula as an oral liquid solution also caters to the older population. For millions of Americans who have family members with AD or are worried about developing AD later in life, this drug could provide hope. Featured photo by Cristina Gottardi on Unsplash. IGC Pharma Inc. (IGC) is at the forefront of the fight against Alzheimer's disease, developing innovative solutions to address this devastating illness. The company's mission is to transform the landscape of Alzheimer's treatment with a robust pipeline of five promising drug candidates. IGC-AD1 and LMP target the hallmarks of Alzheimer's disease, including neuroinflammation, Aβ plaques, and neurofibrillary tangles. IGC-AD1 is currently undergoing a Phase 2b clinical trial for agitation in dementia associated with Alzheimer's (clinicaltrials.gov, CT05543681). TGR-63 disrupts the progression of Alzheimer's by targeting Aβ plaques. IGC-M3, currently in preclinical development, aims to inhibit the aggregation of Aβ plaques, potentially impacting early-stage Alzheimer's. IGC-1C, also in preclinical stages, targets tau protein and neurofibrillary tangles, representing a forward-thinking approach to Alzheimer's therapy. In addition to its drug development pipeline, IGC Pharma is actively leveraging Artificial Intelligence (AI) for Alzheimer's research. Their AI projects encompass various areas, including clinical trial optimization and early detection of Alzheimer's. These forward-looking statements are based largely on IGC Pharma’s expectations and are subject to several risks and uncertainties, certain of which are beyond IGC Pharma’s control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, the Company’s failure or inability to commercialize one or more of the Company’s products or technologies, including the products or formulations described in this release, or failure to obtain regulatory approval for the products or formulations, where required, or government regulations affecting AI or the AI algorithms not working as intended or producing accurate predictions; general economic conditions that are less favorable than expected; the FDA’s general position regarding cannabis- and hemp-based products; and other factors, many of which are discussed in IGC Pharma’s U.S. Securities and Exchange Commission ("SEC") filings. IGC Pharma incorporates by reference the human trial disclosures and Risk Factors identified in its Annual Report on Form 10-K filed with the SEC on July 7, 2023, and Quarterly Report on Form 10-Q filed with the SEC on February 14, 2024, as if fully incorporated and restated herein. Considering these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will occur. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Rosalyn Christian rchristian@imsinvestorrelations.com Company Website https://igcpharma.com/

May 09, 2024 08:45 AM Eastern Daylight Time